AVTX · Avalo Therapeutics, Inc.
Market Cap
$1.03B
Shares
53.63M
Transactions in this listed security by members of the U.S. Congress, disclosed under the STOCK Act. Lawmakers must report trades within 45 days, so the filing date can lag the trade itself.
No Congressional Trades
No congressional trading data is available for this listed security yet.
Key facts
CIK
1534120
CUSIP
05338F306
13F (30d)
101 filings
101 filers
Visit website
Investor relations